Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Von Willebrand Disease, Type 2N”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableLooking for participantsNCT05437536
What this trial is testing

The Severe Von Willebrand Disease (sVWD) Patient Registry

Who this might be right for
VWD - Von Willebrand's Disease
VWD Connect Foundation 400
Early research (Phase 1)Study completedNCT04770935
What this trial is testing

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

Who this might be right for
Von Willebrand's Disease (VWD)
Bioverativ, a Sanofi company 6
Not applicableLooking for participantsNCT06610201
What this trial is testing

Bleeding and Treatment in Participants With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+4 more
Hemab ApS 200